India’s Central Drug Authority May Be Shelved; Four Zones Suggested
This article was originally published in The Tan Sheet
Executive Summary
A parliamentary committee empowered to review provisions of India's proposed Central Drug Authority says the planned agency may not be in the best interest of small- and medium-sized Indian companies